Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Loges, Sonja
BGBC003, NCT02488408: A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS	Completed	1/2	122	Europe, US	Bemcentinib, BGB324, Cytarabine, Ara-C, Decitabine, Dacogen	BerGenBio ASA	Acute Myeloid Leukemia, Myelodysplastic Syndromes	06/22	06/22
CONNECT, NCT05701150: AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO	Recruiting	N/A	3000	Europe	Minimal documentation, Extended documentation	AIO-Studien-gGmbH, Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company, Merck Sharp & Dohme LLC, Janssen-Cilag G.m.b.H	Advanced Solid Tumor	12/25	12/25